Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Population pharmacokinetics modeling of evetiracetam in Chinese children with epilepsy
by
Ying-hui WANG Li WANG Wei LU De-wei SHANG Min-ji WEI Ye WU
in
中国
/ 儿童
/ 动力学建模
/ 北京大学第一医院
/ 癫痫
/ 群体
/ 预测误差
/ 高效液相色谱法
2012
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Population pharmacokinetics modeling of evetiracetam in Chinese children with epilepsy
by
Ying-hui WANG Li WANG Wei LU De-wei SHANG Min-ji WEI Ye WU
in
中国
/ 儿童
/ 动力学建模
/ 北京大学第一医院
/ 癫痫
/ 群体
/ 预测误差
/ 高效液相色谱法
2012
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Population pharmacokinetics modeling of evetiracetam in Chinese children with epilepsy
Journal Article
Population pharmacokinetics modeling of evetiracetam in Chinese children with epilepsy
2012
Request Book From Autostore
and Choose the Collection Method
Overview
Aim: To establish a population pharmacokinetics (PPK) model of levetiracetam in Chinese children with epilepsy. Methods: A total of 418 samples from 361 epileptic children in Peking University First Hospital were analyzed. These patients were divided into two groups: the PPK model group (n=311) and the PPK validation group (n=50). Levetiracetam concentrations were determined by HPLC. The PPK model of levetiracetam was established using NONMEM, according to a one-compartment model with firstorder absorption and elimination. To validate the model, the mean prediction error (MPE), mean squared prediction error (MSPE), root mean-squared prediction error (RMSPE), weight residues (WRES), and the 95% confidence intervals (95% CI) were calculated. Results: A regression equation of the basic model of levetiracetam was obtained, with clearance (CL/F)=O.988 L/h, volume of distribution (V/F)=12.3 L, and Ka=1.95 h-1. The final model was as follows: Ka=1.56 h-1, V/F=12.1 (L), CL/F=1.04x(WEIG/25)63 (L/h). For the basic model, the MPE, MSPE, RMSPE, WRES, and the 95%Cl were 9.834 (-0.587-197.720), 50.919 (0.012-1286.429), 1.680 (0.021-34.184), and 0.0621 (-1.100-1.980). For the final model, the MPE, MSPE, RMSPE, WRES, and the 95% Cl were 0.199 (-0.369-0.563), 0.002082 (0.00001-0.01054), 0.0293 (0.001-0.110), and 0.153 (-0.030-1.950). Conclusion: A one-compartment model with firstrder absorption adequately described the levetiracetam concentrations. Body weight was identified as a significant covariate for levetiracetam clearance in this study. This model will be valuable to facilitate individualized dosage regimens.
MBRLCatalogueRelatedBooks
Related Items
Related Items
We currently cannot retrieve any items related to this title. Kindly check back at a later time.
This website uses cookies to ensure you get the best experience on our website.